Category: Antimicrobial resistance
-
Updates from the field – AVENIR II in November
—
published by
AVENIR II in Niger – November 2024 November saw the successful completion of a number of activities, including the continued mass distribution of azithromycin in the Dosso and Tahoua regions. Outstanding coverage This campaign has enabled coverage areas for the intervention to be extended, particularly in the surveillance integrated health centres (CSIs), of which there…
-
The year in review:
A tribute to Professor Nigel Klein, 1960–2024While it has been a momentous year for the REACH Network, it has also been a year in which the REACH family lost a brilliant and valued member. It is our privilege to pay tribute to Professor Nigel Klein, who died earlier this year after a long illness.
-
AVENIR II in September 2024
September was a busy month for AVENIR, with activities ranging from training courses to meetings with health and district authorities. Preparations for AVENIR II in Zinder With the second phase of the project progressing successfully in the Maradi, Dosso and Tahoua regions, activities will begin in the Zinder region during the last quarter of 2024.…
-
Updates from the AVENIR project in Niger – August 2024
The “Azithromycine pour la Vie des Enfants au Niger” (“Azithromycin to Save the Lives of Children in Niger”) project, known as AVENIR, continues to make significant progress in reducing child mortality and morbidity in Niger. One of the highlights of the AVENIR project in August was the successful completion of data collection on pregnancy history in the Tahoua and Dosso…
-
AVENIR project updates, July 2024
A growing intervention The second phase of the AVENIR project is getting underway in the Dosso region of Niger during the fourth quarter of 2024. In preparation for this intervention, a national coordination team has been assigned to the region to prepare the ground for future activities and to ensure that all stakeholders are fully…
-
-
